IP Library Patent Application 16093943
Patent Application
App. No. 16/093,943

MBTH-LIKE PROTEINS IN EUKARYOTIC NRPS-CATALYZED PROCESSES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/093,943
Abstract

The present invention relates to a method to improve the production of a secondary metabolite catalyzed by a non-ribosomal peptide synthetase comprising contacting in a eukaryotic host a eukaryotic non-ribosomal peptide synthetase with an MbtH-like protein. The present invention further relates to a composition comprising a eukaryotic non-ribosomal peptide synthetase that is not a hybrid and a prokaryotic MbtH and to a eukaryotic host cell comprising a non-ribosomal peptide synthetase and a polynucleotide allowing the expression of an MbtH-like protein.

Claims (31)

1 . A method to improve the production of a secondary metabolite or a precursor occurring in the pathway leading to said secondary metabolite catalyzed by a non-ribosomal peptide synthetase comprising contacting in a eukaryotic host said non-ribosomal peptide synthetase with an MbtH-like protein, characterized in that said non-ribosomal peptide synthetase is from eukaryotic origin and is not a hybrid.

2 . The method according to claim 1 wherein said eukaryotic host is a fungus.

3 . The method according to claim 1 wherein said secondary metabolite is a β-lactam, a pigment or a mycotoxin.

4 . The method according to claim 3 wherein said β-lactam is 6-aminopenicillanic acid, 7-aminodesacetoxycephalosporanic acid, adipyl 7-aminodesacetoxycephalosporanic acid, cephalosporin C, penicillin G or penicillin V, wherein said pigment is a chrysogenin or wherein said mycotoxin is a roquefortin.

5 . The method according to claim 2 wherein said fungus is Penicillium chrysogenum.

6 . The method according to claim 5 wherein said eukaryotic host is a multi copy strain.

7 . The method according to claim 1 wherein said MbtH-like protein has SEQ ID NO: 1-7 or a sequence that is at least 70% homologous to SEQ ID NO: 1-7.

8 . The method according to claim 1 wherein said MbtH-like protein comprises the amino acid code of SEQ ID NO: 17.

9 . The method according to claim 8 wherein said MbtH-like protein comprises the amino acid code of any one of SEQ ID NO: 18 to SEQ ID NO: 53 or SEQ ID NO: 57 to SEQ ID NO: 92.

10 . A composition comprising a eukaryotic non-ribosomal peptide synthetase that is not a hybrid and a prokaryotic MbtH.

11 . The composition according to claim 10 which is

SEQ ID NO: 54 with SEQ ID NO: 1; or

SEQ ID NO: 54 with SEQ ID NO: 3; or

SEQ ID NO: 54 with SEQ ID NO: 4; or

SEQ ID NO: 54 with SEQ ID NO: 6; or

SEQ ID NO: 54 with SEQ ID NO: 7; or

SEQ ID NO: 55 with SEQ ID NO: 1; or

SEQ ID NO: 55 with SEQ ID NO: 3; or

SEQ ID NO: 55 with SEQ ID NO: 4; or

SEQ ID NO: 55 with SEQ ID NO: 6; or

SEQ ID NO: 55 with SEQ ID NO: 7; or

SEQ ID NO: 56 with SEQ ID NO: 1; or

SEQ ID NO: 56 with SEQ ID NO: 3; or

SEQ ID NO: 56 with SEQ ID NO: 4; or

SEQ ID NO: 56 with SEQ ID NO: 6; or

SEQ ID NO: 56 with SEQ ID NO: 7; or

sequences that are at last 90% homologous thereto.

12 . A eukaryotic host cell comprising a non-ribosomal peptide synthetase that is not a hybrid and a polynucleotide allowing the expression of an MbtH-like protein, characterized in that said non-ribosomal peptide synthetase is from eukaryotic origin.

13 . The eukaryotic host cell according to claim 12 wherein said MbtH-like protein has SEQ ID NO: 1-7 or a sequence that is at least 70% homologous to SEQ ID NO: 1-7.

14 . The eukaryotic host cell according to claim 12 wherein said MbtH-like protein comprises the amino acid code of SEQ ID NO: 17.

15 . The eukaryotic host cell according to claim 12 which is Penicillium chrysogenum.

Assignments (1)
CHANGE OF NAME Recorded Apr 2, 2019
From: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.
To: CENTRIENT PHARMACEUTICALS NETHERLANDS B.V.
Reel/Frame 048775/0029 →